Format

Send to

Choose Destination
Ann Clin Biochem. 2012 Jul;49(Pt 4):399-401. doi: 10.1258/acb.2011.011195. Epub 2012 Apr 27.

Serum 25 hydroxy-vitamin D does not exhibit an acute phase reaction after acute myocardial infarction.

Author information

1
Clinical Biochemistry, Leeds General Infirmary, Leeds LS1 3EX, UK. julian.barth@leedsth.nhs.uk

Abstract

BACKGROUND:

There is growing epidemiological evidence linking serum 25 hydroxy-vitamin D (25(OH)D) concentrations to outcome in cardiovascular and other diseases. We have studied patients with acute myocardial infarction (AMI) to determine if they exhibit an acute phase reaction affecting 25(OH)D.

METHODS:

Patients (n=32) with first AMI who had been treated with primary percutaneous coronary intervention within 12 h of symptom onset had venous blood samples taken two days, one week, one month and three months after presentation. Samples were analysed for troponin I, C-reactive protein (CRP) and 25(OH)D.

RESULTS:

All patients had significant rises in troponin confirming the myocardial damage and CRP, both of which resolved by 28 days. In contrast, 25(OH)D remained unchanged throughout the 90-day observation period with a median concentration of 46 nmol/L.

CONCLUSION:

Serum 25(OH)D does not change after AMI and is likely to be a reliable marker of vitamin D status in patients with cardiovascular disease.

PMID:
22543926
DOI:
10.1258/acb.2011.011195
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center